Background
==========

Long QT syndrome (LQTS) is a disorder of cardiac repolarization characterized by prolonged QT intervals and abnormal T waves on surface electrocardiograms (ECG), *torsade de pointes*, and sudden death \[[@B1]-[@B3]\]. Two forms of inherited LQTS have been described: Romano-Ward syndrome (RWS), which is an autosomal dominant form of LQTS without sensorineural deafness, and Jervell and Lange-Nielsen syndrome (JLNS), which is an autosomal recessive form of LQTS associated with deafness \[[@B4]-[@B6]\].

RWS is the most common form of inherited LQTS \[[@B7]\]. More than nine genes have been identified for RWS:*KCNQ1*(or *KvLQT1*, LQT1) \[[@B8]\] on chromosome 11p15.5, *KCNH2*(or *HERG*, LQT2) on chromosome 7q35-36 \[[@B9]\], *SCN5A*(LQT3) on chromosome 3p21 \[[@B10],[@B11]\], *Ankyrin-B*(LQT4) on chromosome 4q25-27 \[[@B12]\], *KCNE1*(LQT5) on chromosome 21q22 \[[@B13],[@B14]\], *KCNE2*(LQT6) on chromosome 21q22 \[[@B15]\], *KCNJ2*(LQT7) 17q23.1 \[[@B16]\], *CACNA1C*(LQT8) on chromosome 12p13.3 \[[@B17]\], and *CAV3*(LQT9) on chromosome 3p25 \[[@B18]\]. Carriers with mutations in *KCNJ2*and *CACNA1C*exhibit not only the LQTS phenotype but other phenotypes as well (designated as Andersen syndrome and Timothy syndrome, respectively) \[[@B16],[@B17]\].

JLNS is a rare autosomal recessive disorder that appears to have a worse prognosis than RWS \[[@B19]\]. JLNS can be caused by homozygous or compound heterozygous mutations in either *KCNQ1*or *KCNE1*\[[@B13],[@B20]-[@B27]\]. *KCNQ1*encodes a potassium channel gene with six transmembrane domains and forms functional I~Ks~potassium channels by assembling with minK (encoded by *KCNE1*) in the heart \[[@B8],[@B28]\].

In this report, we identified a novel mutation in the *KCNQ1*gene that simultaneously caused RWS and JLNS within a Chinese family. The results expand the spectrum of *KCNQ1*mutations causing RWS and JLNS.

Results
=======

One three-generation JLN/RWS family was identified in China and clinically evaluated. The pedigree structure of the family is shown in Figure [1](#F1){ref-type="fig"}, and clinical characteristics for family members are listed in Table [1](#T1){ref-type="table"}. The proband (patient III:1) had been deaf since birth. At 3 years of age, she was referred for detailed examinations due to syncope. Since then, she has experienced 11 additional syncopal episodes, most of which were preceded by exercise and sport. Current ECG analysis revealed a markedly prolonged QTc ranging from 0.520 to 0.608 s (a representative ECG is shown in Figure [2](#F2){ref-type="fig"}). She was then diagnosed as having JLNS (deafness + LQTS). Interestingly, the proband was also affected with atrial fibrillation. The proband\'s brother (patient III:2, Figure [1](#F1){ref-type="fig"}) was also affected with deafness and LQTS (JLNS). His QTc ranged from 0.512 s to 0.627 s, and he had experienced three syncopal episodes in the past triggered by exercise and sport. Their parents had normal hearing and normal ECGs with a QTc of 0.42 s (father) and 0.43 s (mother). Individual II:1 had experienced one syncopal episode triggered by exercise when she was 20 years old. No syncope was identified for individual II:2, but he had experienced palpitation and dyspnea. The parents\' marriage was not consanguineous.

###### 

Genotype-phenotype correlation in the Chinese family with both RWS and JLNS and KCNQ1 mutation T322M

  **ID**   **Sex/Age**   **Deafness**   **Symptoms**                                         **QTc (s)**         **Genotype**
  -------- ------------- -------------- ---------------------------------------------------- ------------------- --------------
  I:1      M/71          No             None                                                 0.420               T322 T322
  I:2      F/65          No             Chest discomfort                                     0.487               T322 M322
  II:1     F/42          No             1 syncope (trigger, exercise)                        0.430               T322 M322
  II:2     M/43          No             Palpitation, dyspnea                                 0.420 0.410 0.400   T322 M322
  II:3     F/39          No             None                                                 0.400               T322 T322
  II:4     F/36          No             dyspnea, palpitation                                 0.455 0.454 0.444   T322 M322
  III:1    F/17          Yes            12 syncope (trigger, exercise) Atrial fibrillation   0.520 0.608         M322 M322
  III:2    M/8           Yes            3 syncope (trigger, exercise)                        0.512 0.627         M322 M322
  III:3    M/16          No             None                                                 0.397               T322 T322
  III:4    M/9           No             None                                                 0.447               T322 M322

![Pedigree structure of the Chinese family with JLNS and RWS. The results of RFLP analysis for mutation T322M are shown below each symbol. Affected male III:1 and females I:2 and III:2 are indicated with filled squares and circles; normal members are indicated with open symbols; individual III:4 with borderline QTc is shown with a gray symbol. QTc for family members is shown below each symbol as ms. The three-generation family is notable for the proband (III:1, indicated by an arrow) and her brother (III:2), who were affected with deafness and had a severely prolonged QTc.](1471-2350-9-24-1){#F1}

![Representative electrocardiograms (ECG) from members of the Chinese family with LQTS. Top, ECG from a normal family member (I-1); Middle, ECG from a heterozygous mutation carrier; Bottom, ECG from a homozygous mutation carrier.](1471-2350-9-24-2){#F2}

Further analysis of other family members identified two other members affected with RWS. Individual II:4 was clinically diagnosed with LQTS because she had a moderately prolonged QTc of 0.455 s and a medical history of dyspnea and palpitation. Her mother (I:2, Figure [1](#F1){ref-type="fig"}) was also affected with LQTS with a prolonged QTc of 0.487 s. Both I:2 and II:4 had normal hearing. Individual III:4 was a male with a borderline QTc of 0.447 s. No stress testing was performed for III:4 or other family members. Individuals I:1, II:3, and III:3 had a normal QTc of 0.420 s, 0.400 s, and 0.397 s, respectively.

A homozygous C → T transition was identified at nucleotide 965 in exon 7 of *KCNQ1*in the DNA sample from the proband (Figure [3](#F3){ref-type="fig"}). The C to T change resulted in the substitution of a threonine residue by a methionine residue at codon 322 (T322M) (Figure [3](#F3){ref-type="fig"}). The homozygous T322M mutation was also identified in the proband\'s brother (individual III:2, Figure [1](#F1){ref-type="fig"}). The parents and family members II:4 and I:2 were heterozygous for the mutation.

![Identification of KCNQ1 mutation T322M (T to C substitution at nucleotide 965). Top, normal sequence; Middle, heterozygous T322M mutation with both T and C at nucleotide 965; Bottom, homozygous T322M mutation.](1471-2350-9-24-3){#F3}

The detection of mutation T322M was further confirmed by RFLP analysis showing the presence of only the mutant allele (M322) in the proband and her brother (Figure [1](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}). RFLP analysis also demonstrated that family members II:1, II:2, I:2, II:4, and III:4 were heterozygous for the mutation (T322 and M322) and that normal individuals I:1, II:3, and III:3 carried the wild type T322 allele. The M322 allele was not identified in 200 normal Chinese Han nationality controls (data not shown).

Discussion
==========

In this report, we describe a Chinese family in which a heterozygous mutation in *KCNQ1*, T322M, resulted in RWS whereas the homozygous mutation resulted in JLNS associated with LQTS and deafness. Heterozygous mutations in the *KCNQ1*gene have been reported in Chinese patients with RWS, but no *KCNQ1*mutation associated with JLN has been reported in the Chinese population \[[@B29]\]. Thus, the T322M is the first *KCNQ1*mutation identified for JLN in the Chinese population.

The penetrance of the phenotype in the family members with homozygous T322M was complete. The two homozygous mutation carriers, III:1 and III:2 (Figure [1](#F1){ref-type="fig"}), had a markedly prolonged QTc of up to 0.608 s and 0.627 s, respectively, and both had experienced multiple syncopal episodes triggered by exercise and sport. These results are consistent with the finding by Schwartz et al. \[[@B24]\] that JLN is a more severe variant of LQTS than RWS. Interestingly, individual III:1 was affected by both LQTS and atrial fibrillation. Previously, in a Chinese family with atrial fibrillation and KCNQ1 mutation S140G, multiple family members had both LQTS and atrial fibrillation \[[@B30]\]. Further studies are needed to determine whether and how the T322M mutation is associated with atrial fibrillation.

The penetrance of the phenotype of QTc prolongation in heterozygous mutation carriers was not complete. Two carriers, II-1 and II-2, had a normal QTc (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). On the other hand, two carriers, I-2 and II:4, were affected with RWS. The other carrier, III-4, had borderline QTc prolongation. The molecular mechanism that is responsible for the intra-familial variability or variable penetrance of the LQTS phenotype in heterozygous carriers is not clear, but environmental factors and modifying genes are likely possibilities.

Conclusion
==========

This study identified a novel mutation, T322M, in the *KCNQ1*gene that caused RWS with high intrafamilial variability in the heterozygous carriers and typical JLNS in the homozygous carriers within a Chinese family. To the best of our knowledge, T322M is the first mutation identified for JLNS in the Chinese population.

Methods
=======

Study subjects, clinical diagnosis, and isolation of human genomic DNA
----------------------------------------------------------------------

The LQTS family was identified in the Henan Province of China. Informed consent was obtained from all the participants or their guardians. This study complied with the Helsinki Declaration and was approved by the ethics committee of Huazhong University of Science and Technology.

LQTS was diagnosed based on the presence of prolonged QT intervals as seen on a 12-lead ECG and a medical history of syncope, dyspnea, and palpitation. The QT interval was manually measured, and the QTc was calculated using Bazett\'s formula for heart rate correction \[[@B31]\]. The diagnosis of LQTS was based on the work of Schwartz et al. \[[@B32]\] and others \[[@B8],[@B10],[@B11]\]. Asymptomatic individuals with a QTc of ≥ 0.47 s and symptomatic individuals (syncope, dyspnea, palpitation) with a QTc ≥ 0.45 s were diagnosed with LQTS. Males with a QTc of \<0.44 s and females with a QTc of \<0.45 s were considered normal. All others were diagnosed as having borderline QTc.

Peripheral blood was collected from the participants, and their total human genomic DNA was isolated using the DNA Isolation Kit for Mammalian Blood (Roche Diagnostic Co., Indianapolis, IN).

Mutational analyses
-------------------

Mutation screening was performed using direct DNA sequence analysis. The exons and exon-intorn boundaries of the *KCNQ1*gene were amplified with polymerase chain reaction (PCR). PCR was performed in a 25-μL volume containing 50 mmol/L KCl, 10 mmol/L Tris-HCl, pH 8.3, 1.5 mmol/L MgCl~2~, 0.2 mmol/L of each dNTP, 0.5 μmol/L of each primer, 1 U of *Taq*polymerase (TaKaRa Biotechnology Co.), and 50 ng of genomic DNA. The amplification program consisted of one cycle of denaturation at 94°C for 3 min, 35 cycles of 94°C for 30 s, 50°C to 60°C for 30 s (with different annealing temperatures for different primer pairs), 72°C for 1 min, and one cycle of extension at 72°C for 7 min. Each PCR product was separated by a 1.5% agarose gel, purified using the QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA) and sequenced with the forward and reverse primers using the BigDye Terminator Cycle Sequencing v3.1 kit (Applied Biosystems, Inc.).

Mutation designation was based on the cDNA sequence for KCNQ1 transcript variant 1 (Genbank accession No. [NM_000218](NM_000218)).

Mutation T322M disrupted a *MaeI*restriction site, which allowed the restriction fragment length polymorphism (RFLP) analysis to confirm the mutation in family members and to test whether the mutation was present in the controls. Using PCR, we amplified exon 7 of *KCNQ1*, which contained the T322M mutation from all members of the family as well as 200 unrelated healthy Chinese individuals of Han nationality. The PCR product was 291 bp in length and the primers were 5\'-AGAGTGGTGGGTTTGGGTTAG-3\' (forward primer) and 5\'-GAACGTAAGTGGGTCTGCTCA-3\' (reverse primer). The PCR product was digested by two units of *MaeI*at 65°C overnight and separated on a 2.5% agarose gel.
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